Introduction
The World Health Organization (WHO) has recently taken a significant step toward mitigating the spread of Mpox by issuing an Emergency Use Listing (EUL) for an in vitro diagnostic test. This test, crucial for…
“Sepsis is more deadly than heart attack and stroke combined — in fact it’s the deadliest, costliest, and arguably most complex condition facing hospitals today.”
Those remarks came from Ajay Shah, CEO of San Francisco-based…
Continue Reading
PocDoc’s home testing kit for cardiovascular disease (CVD) is to be integrated with the NHS App, allowing patients to see test results on their NHS patient record.Work is underway to complete the integration of…
Continue Reading
Diagnostics startup Geneoscopy earned its first-ever FDA approval this week.
The St. Louis-based company received approval for ColoSense, its noninvasive colorectal cancer screening test. The test — which the FDA designated as a breakthrough device…
Continue Reading
Ensuring diagnostic performance of artificial intelligence (AI) before introduction into clinical practice is essential. Growing numbers of studies using AI for digital pathology have been reported over recent years. The aim of this work…
Continue Reading
Cytovale, a medical diagnostics company focused on developing technology that helps diagnose diseases, announced it scored $84 million in Series C funding led by Norwest Venture Partners with participation from other investors. WHAT THEY DO
Cytovale…
Sepsis kills more than 11 million people worldwide each year and contributes to 20% of all global deaths. The disease is also a leading cause of death in U.S. hospitals, and a septic patient’s…
Continue Reading
